MDxHealth SA
MDXH
$0.69
-$0.02-3.01%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 22.56% | 25.46% | 33.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 22.56% | 25.46% | 33.01% |
| Cost of Revenue | -- | -- | 19.63% | 28.07% | 28.60% |
| Gross Profit | -- | -- | 24.30% | 23.91% | 35.89% |
| SG&A Expenses | -- | -- | 3.62% | 7.29% | 11.60% |
| Depreciation & Amortization | -- | -- | -32.67% | -43.22% | 5.34% |
| Other Operating Expenses | -- | -- | 287.80% | 466.91% | -128.56% |
| Total Operating Expenses | -- | -- | 10.22% | 16.34% | 17.91% |
| Operating Income | -- | -- | 30.20% | 10.91% | 13.77% |
| Income Before Tax | -- | -- | 15.45% | 4.17% | 6.91% |
| Income Tax Expenses | -- | -- | 11,200.00% | 52,800.00% | 169.53% |
| Earnings from Continuing Operations | -- | -- | 15.18% | 2.84% | 6.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | 15.18% | 2.84% | 6.40% |
| EBIT | -- | -- | 30.20% | 10.91% | 13.77% |
| EBITDA | -- | -- | 49.05% | 22.19% | 20.28% |
| EPS Basic | -- | -- | 41.50% | 22.50% | 27.22% |
| Normalized Basic EPS | -- | -- | 89.56% | 35.96% | 65.14% |
| EPS Diluted | -- | -- | 41.50% | 22.50% | 27.22% |
| Normalized Diluted EPS | -- | -- | 89.56% | 35.96% | 65.14% |
| Average Basic Shares Outstanding | -- | -- | 61.89% | 41.75% | 21.32% |
| Average Diluted Shares Outstanding | -- | -- | 61.89% | 41.75% | 21.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |